Cellular/JJ
immune/JJ
and/CC
cytokine/NN
pathways/NNS
resulting/VBG
in/IN
tissue/NN
factor/NN
expression/NN
and/CC
relevance/NN
to/TO
septic/JJ
shock/NN
./.

Cells/NNS
of/IN
monocyte/NN
lineage/NN
serve/VBP
as/IN
effector/NN
cells/NNS
in/IN
the/DT
cellular/JJ
immune/JJ
response/NN
./.
=====
In/IN
addition/NN
,/,
they/PRP
respond/VBP
to/TO
LPS/NN
and/CC
cytokines/NNS
with/IN
activation/NN
and/CC
expression/NN
of/IN
inflammatory/JJ
effector/NN
gene/NN
products/NNS
similar/JJ
to/TO
those/DT
elicited/VBN
by/IN
the/DT
antigen/NN
driven/JJ
response/NN
./.
=====
The/DT
response/NN
to/TO
antigen/NN
proceeds/VBZ
at/IN
the/DT
T/NN
helper/NN
cell/NN
level/NN
through/IN
two/CD
independent/JJ
forms/NNS
of/IN
cellular/JJ
collaboration/NN
,/,
contact/NN
and/CC
lymphokine/NN
./.
=====
We/PRP
review/VBP
the/DT
control/NN
of/IN
expression/NN
of/IN
the/DT
Tissue/NN
Factor/NN
(/(
TF/NN
)/)
gene/NN
and/CC
the/DT
function/NN
of/IN
the/DT
TF/NN
protein/NN
./.
=====
The/DT
enhanced/VBN
initiation/NN
of/IN
transcription/NN
of/IN
the/DT
TF/NN
gene/NN
appears/VBZ
to/TO
require/VB
engagement/NN
of/IN
a/DT
56/CD
bp/NN
LPS/NN
Response/NN
Element/NN
,/,
an/DT
enhancer/NN
that/WDT
is/VBZ
engaged/VBN
by/IN
both/DT
AP-1/NN
type/NN
heterodimeric/JJ
complexes/NNS
as/RB
well/RB
as/IN
NF/NN
kappa/NN
B/NN
like/IN
heterodimeric/JJ
complexes/NNS
./.
=====
Dissociation/NN
of/IN
NF/NN
kappa/NN
B/NN
from/IN
Ig/NN
kappa/NN
B/NN
by/IN
cytokine/NN
and/CC
LPS/NN
stimulation/NN
,/,
and/CC
possibly/RB
activated/VBN
T/NN
cells/NNS
,/,
may/MD
represent/VB
a/DT
common/JJ
pathway/NN
to/TO
induction/NN
of/IN
the/DT
TF/NN
and/CC
other/JJ
inflammatory/JJ
genes/NNS
./.
=====
Enhancement/NN
of/IN
expression/NN
of/IN
TF/NN
is/VBZ
observed/VBN
upon/IN
adhesion/NN
of/IN
Mo/NN
to/TO
endothelial/JJ
cells/NNS
and/CC
extracellular/JJ
matrix/JJ
proteins/NNS
,/,
as/RB
well/RB
as/IN
upon/IN
engagement/NN
of/IN
leukocyte/NN
integrins/NNS
./.
=====
The/DT
biological/JJ
effects/NNS
that/WDT
follow/VBP
from/IN
expression/NN
of/IN
TF/NN
by/IN
vascular/JJ
cells/NNS
have/VBP
been/VBN
resolved/VBN
by/IN
analysis/NN
of/IN
function/NN
aided/VBN
by/IN
the/DT
use/NN
of/IN
recombinant/JJ
full/JJ
length/NN
TF/NN
and/CC
truncated/VBN
surface/NN
domain/NN
of/IN
TF/NN
./.
=====
The/DT
rules/NNS
of/IN
assembly/NN
of/IN
the/DT
cognate/JJ
ligands/NNS
of/IN
TF/NN
,/,
namely/RB
the/DT
zymogen/NN
plasma/NN
factors/NNS
VII/NN
and/CC
the/DT
serine/NN
protease/NN
factor/NN
VIIa/NN
,/,
with/IN
the/DT
soluble/JJ
surface/NN
domain/NN
of/IN
TF/NN
in/IN
free/JJ
solution/NN
,/,
in/IN
the/DT
presence/NN
of/IN
phospholipid/JJ
surfaces/NNS
and/CC
cell/NN
surface/NN
and/CC
of/IN
the/DT
anchored/VBN
TF/NN
molecule/NN
have/VBP
been/VBN
described/VBN
./.
=====
It/PRP
is/VBZ
evident/JJ
that/IN
assembly/NN
of/IN
the/DT
surface/NN
domain/NN
of/IN
TF/NN
with/IN
VIIa/NN
to/TO
form/VB
the/DT
binary/JJ
TF.VIIa/NN
complex/NN
induces/VBZ
a/DT
significant/JJ
increase/NN
in/IN
the/DT
Kcat/NN
of/IN
the/DT
catalytic/JJ
domain/NN
of/IN
VIIa/NN
for/IN
small/JJ
peptidyl/JJ
substrates/NNS
and/CC
more/JJR
profoundly/RB
for/IN
protein/NN
substrate/NN
./.
=====
This/DT
provides/VBZ
substantial/JJ
evidence/NN
for/IN
an/DT
allosteric/JJ
effect/NN
on/IN
the/DT
catalytic/JJ
cleft/NN
of/IN
VIIa/NN
that/WDT
is/VBZ
imparted/VBN
by/IN
binding/VBG
to/TO
TF/NN
,/,
its/PRP$
cognate/JJ
catalytic/JJ
cofactor/NN
./.
=====
It/PRP
is/VBZ
also/RB
evident/JJ
that/IN
the/DT
TF.VIIa/NN
complex/NN
is/VBZ
proteolytically/RB
active/JJ
and/CC
can/MD
activate/VB
the/DT
zymogen/NN
plasma/NN
factor/NN
X/NN
to/TO
the/DT
serine/NN
protease/NN
Xa/NN
in/IN
free/JJ
solution/NN
,/,
inferring/VBG
that/IN
extended/VBN
substrate/NN
recognition/NN
by/IN
induced/VBN
structural/JJ
loci/NNS
of/IN
the/DT
TF.VIIa/NN
complex/NN
are/VBP
created/VBN
from/IN
either/DT
or/CC
both/DT
proteins/NNS
to/TO
constitute/VB
a/DT
new/JJ
recognition/NN
structure/NN
./.
=====
It/PRP
is/VBZ
also/RB
evident/JJ
that/IN
association/NN
of/IN
X/NN
with/IN
charged/JJ
phospholipid/JJ
surfaces/NNS
enhances/VBZ
the/DT
proteolytic/JJ
activation/NN
of/IN
this/DT
zymogen/NN
by/IN
increasing/VBG
recognition/NN
and/CC
susceptibility/NN
of/IN
the/DT
sessile/NN
peptide/NN
bond/NN
deduced/VBN
from/IN
the/DT
markedly/RB
decreased/VBN
Km/NN
and/CC
increased/VBN
Kcat/NN
./.